BioCryst

+$0.37 (+3.05%) As of 6:12 PM UTC today

Why Robinhood?

You can buy or sell BioCryst and other stocks, options, and ETFs commission-free!

About BCRX

BioCryst Pharmaceuticals, Inc. Common Stock, also called BioCryst, is a commercial-stage biotechnology company, which engages in the development and discovery of novel, oral, and small-molecule medicines.

CEO

Jon P. Stonehouse

Employees

246

Headquarters

Durham, North Carolina

Founded

1986

BCRX Key Statistics

Market Cap

2.44B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

4.95M

High Today

$12.67

Low Today

$11.90

Open Price

$12.09

Volume

2.30M

52 Week High

$14.24

52 Week Low

$3.30

BCRX News

BenzingaMay 6

Why BioCryst Pharmaceuticals' Stock Is Trading Higher Today - BioCryst Pharmaceuticals

BioCryst Pharmaceuticals (NASDAQ:BCRX) shares are trading higher after the company reported better-than-expected Q1 sales results. BioCryst Pharmaceuticals' st

Analyst Ratings

82%

of 11 ratings

Buy

81.8%

Hold

18.2%

Sell

BCRX Earnings

-$0.36

-$0.24

-$0.12

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

-$0.27 per share

Actual

-$0.36 per share

Replay Earnings Call